MRD / Regn No. : 20260000286 Date : 01/07/2026
Patient Name : Mohammad Azad Age & Gender : 54 Yrs. / Male
Contact No. : 6001990069 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NKA Referred By :
   
Subjective : TYPE 2 DM FOR 6 YEARS,UNABLE TO TOLERATE PROTEIN INTAKE
Objective : NONE
Analysis : TYPE 2 DM,ANEMIA,DYSLIPIDEMIA,A2G1 DKD,DISTAL SENSORY NEUROPATHY
Plan : INCREASE SEMALIX TO 0.5 MG,SEE ME IN 1 MONTH  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 156 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 194 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 0-16-0 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
2 SGLT2I EMPAGLIFLOZIN 10 MG
JARDIANCE
Medicine For DIABETES OBESITY HEART AND KIDNEY PROTECTION
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE GENITOURINARY INFECTIONS
3 TELMISARTAN 40 MG
ERITEL 40 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
4 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
5 INJECTION SEMAGLUTIDE 0.5 MG
SEMALIX 0.5
Medicine For DIABETES OBESITY HEART KIDNEY PROTECTION
SQ EVERY WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA CONSTIPATION OR VISUAL DISTURBANCE
       
Refill : 0 / Substitution:    
Education :
Next Visit : 31/Jul/2026
Tests Suggested For Next Visit : FBS 2HPP SMBG HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

Disclaimer: This is an ONLINE consultation. The patient has not been physically examined. The prescription or advice is based on the patient's description of the problem which is given above and also explained over video consultation.
This is a Computer generated Prescription

Powered By: